Streetbeat News

Equity Actions

ROOT

Root Inc. has not received any proposal that is actionable or in the best interests of shareholders. The company's Board of Directors continues to evaluate any bona fide proposal or opportunity to enhance shareholder value.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 8:06 pm

FARO

FARO Technologies has announced the appointment of Peter Lau as President and Chief Executive Officer, effective from July 24th, 2023. Lau, who recently served as CEO of Catalyst Nutraceuticals and held senior positions at Hubbell, Honeywell, and General Electric, will replace Yuval Wasserman, who will continue as the company's Executive Chairman. FARO is a global leader in 3D measurement, imaging, and realization solutions.

Portfolio Pulse from Happy Mohamed

June 29, 2023 | 8:06 pm

ENVX

Enovix Corporation has announced that Farhan Ahmad will take over as CFO from Steffen Pietzke, effective July 9.

Portfolio Pulse from Benzinga Newsdesk

June 29, 2023 | 8:02 pm

HCP

HashiCorp, Inc. (NASDAQ:HCP) has been added to the Russell 3000 Index, a broad-market index that captures the 4,000 largest U.S. stocks by market capitalization. The inclusion is seen as a recognition of HashiCorp's solid performance and value delivery to shareholders. HashiCorp's products are used by over 20% of the Global 2000, including major companies like AstraZeneca, Autodesk, Blackstone, Comcast, Deutsche Bank, JPMorgan Chase, and others.

Portfolio Pulse from Happy Mohamed

June 29, 2023 | 7:33 pm

DMTTF

UK-based biotech firm Small Pharma Inc. (OTCQB:DMTTF) reported a net loss of $17.2 million for the fiscal year ended Feb. 28, 2023, compared to $16.7 million in FY2022. The company's cash reserves decreased to $13.9 million from $30.6 million over the same period. Small Pharma is implementing a cost-cutting strategy to reduce its annual cash burn and extend its runway to Q4 2024. The company's DMT-related compounds, SPL026 and SPL028, have shown progress in clinical trials, with positive outcomes in a Phase 2a trial for SPL026 and preliminary findings validating the target drug profile for SPL028.

Portfolio Pulse from Lara Goldstein

June 29, 2023 | 6:55 pm

LVS

A significant bullish stance has been taken on Las Vegas Sands (NYSE:LVS) by a large investor, as indicated by unusual options activity. The sentiment among these big-money traders is 60% bullish and 40% bearish. The whales have been targeting a price range from $45.0 to $67.5 for Las Vegas Sands over the last 3 months. Jefferies has downgraded its action to Hold with a price target of $65, while JP Morgan maintains their Overweight rating with a price target of $72.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 6:49 pm

T

A significant amount of unusual options activity has been observed for AT&T (NYSE:T), with a split sentiment of 50% bullish and 50% bearish among big-money traders. The options trades have targeted a price range from $3.0 to $34.0 for AT&T over the last 3 months. HSBC has maintained their Buy rating on AT&T with a price target of $19, while MoffettNathanson upgraded its action to Market Perform with a price target of $17.

Portfolio Pulse from Benzinga Insights

June 29, 2023 | 6:49 pm

ANY

Shares of Sphere 3D Corp (NASDAQ:ANY) are down by 9.8% following the company's implementation of a 1-for-7 reverse stock split. The move, approved by shareholders on June 23, aims to increase the per share trading price and meet the minimum bid price requirement of $1.00 for continued listing on the Nasdaq Capital Market.

Portfolio Pulse from Henry Khederian

June 29, 2023 | 6:40 pm

AYI

BTAI

GNLN

IMNM

MOBQ

SGTX

WAVE

US stocks traded higher with the Dow Jones gaining more than 200 points. Acuity Brands reported better-than-expected earnings for its third quarter but missed the consensus on net sales. Sigilon Therapeutics shares shot up 505% after Eli Lilly agreed to acquire the company. Shares of Eco Wave Power Global and Immunome also rose after announcing a share repurchase program and a definitive merger agreement respectively. BioXcel Therapeutics, Greenlane Holdings, and Mobiquity Technologies shares dropped after releasing topline results from a Phase 3 trial, announcing a public offering, and reporting pricing of a public offering respectively.

Portfolio Pulse from Lisa Levin

June 29, 2023 | 6:32 pm

MRCY

Mercury Systems Inc (NASDAQ:MRCY) has appointed David Farnsworth as CFO, effective July 17, 2023. Farnsworth was previously the CFO of HawkEye 360. The company also announced the appointment of Roger Krone as an independent director, effective June 28, 2023. MRCY shares are trading higher by 2.13% at $33.57.

Portfolio Pulse from Shivani Kumaresan

June 29, 2023 | 6:23 pm